OTHER NEUROSCIENCE — Percent Change (as a percent)
Johnson & Johnson OTHER NEUROSCIENCE — Percent Change (as a percent) increased by 39.3% to -5.4% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.4%, from -19.6% to -5.4%. Over 2 years (FY 2021 to FY 2024), OTHER NEUROSCIENCE — Percent Change (as a percent) shows a downward trend with a 92.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A positive percentage indicates segment growth and momentum, whereas a negative percentage signals a contraction in demand or market share for these specific products.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the company's secondary neuros...
Peer comparison
Comparable to segment-level revenue growth rates reported by peers in the pharmaceutical and biotechnology sectors, used to benchmark relative performance against industry trends.
jnj_segment_other_neuroscience_percent_change_as_a_percentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 15.1% | 3.1% | 0.5% | -3.5% | -15.2% | -1.9% | -9.1% | -9.4% | -10.9% | -13.2% | -18.5% | -23.7% | -17.4% | -4.4% | -19.6% | -8.4% | -8.9% | -5.4% |
| QoQ Change | — | -79.5% | -83.9% | -800.0% | -334.3% | +87.5% | -378.9% | -3.3% | -16.0% | -21.1% | -40.2% | -28.1% | +26.6% | +74.7% | -345.5% | +57.1% | -6.0% | +39.3% |
| YoY Change | — | — | — | — | -200.7% | -161.3% | <-999% | -168.6% | +28.3% | -594.7% | -96.8% | -117.4% | -31.8% | — | -5.9% | +64.6% | +48.9% | +72.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other neuroscience — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported other neuroscience — percent change (as a percent) of -5.4% in Q1 2026.
- How has Johnson & Johnson's other neuroscience — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's other neuroscience — percent change (as a percent) increased by 72.4% year-over-year, from -19.6% to -5.4%.
- What is the long-term trend for Johnson & Johnson's other neuroscience — percent change (as a percent)?
- Over 2 years (2021 to 2024), Johnson & Johnson's other neuroscience — percent change (as a percent) has grown at a 92.9% compound annual growth rate (CAGR), from 17.2% to -64.0%.
- What does other neuroscience — percent change (as a percent) mean?
- The percentage growth rate of revenue for the company's secondary neuroscience product segment compared to the previous period.